Loss of heterozygosity of PTEN, P53, K-ras, HNPCC mutations. BRCA1 and 2 inactivating mutation. ABCG2 overexpression, β-Catenin expression. Here, BRCA1 is linked to hereditary nonpolyposis colon cancer.